Australia
Scenesse is an under-the-skin implant. The drug is the company’s only approved product.
Imugene Limited, a clinical stage immuno-oncology company, announced comprehensive clinical data results from the Phase Ib clinical study of its HER-Vaxx anti-cancer vaccine were presented at the European Society of Medical Oncology in Barcelona, Spain held from 27 September to 1 October 2019.
Imugene Limited announced two presentations by medical investigators at the European Society of Medical Oncology in Barcelona Spain showed combining its HER2 vaccines with PD1 vaccines reduced cancer growth in a number of standard preclinical models.
On Monday, the House Republican resigned his congressional seat ahead of the expected plea.
Immutep Limited announces that the requisite number of predefined patient responses has been exceeded in cohort 1 of Part A) of the TACTI-002 Phase II clinical trial based on an interim analysis.
CEO of gut health testing specialists Microba, Blake Wills, presented at the Google Cloud Summit in Sydney last week to share how working with global powerhouse Google Cloud allowed the startup to combine expert scientific knowledge with high-powered analytics and machine learning capabilities.
Immutep Limited announces that it will receive a milestone payment from GSK of GBP 4 million related to the the first patient being dosed in GSK’s Phase II clinical trial evaluating GSK2831781 in ulcerative colitis.
Immutep Limited announces that it will receive a milestone payment from GSK of £4 million related to the first patient being dosed in GSK’s Phase II clinical trial evaluating GSK2831781 in ulcerative colitis.
Race Oncology Limited is pleased to announce that prominent biotechnology investor and substantial Race shareholder, Dr Daniel Tillett, has joined the Board of Directors of Race Oncology Ltd.
Brisbane-based world leaders in metagenomic testing, Microba, are among 56 finalists competing for a Lord Mayor’s Award in October this year, as a finalist in the product innovation category.
PRESS RELEASES